Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

FXR activation protects against NAFLD via bile-acid-dependent reductions in lipid absorption
Bethan L. Clifford, Leslie R. Sedgeman, Kevin J. Williams, et al.
Cell Metabolism (2021) Vol. 33, Iss. 8, pp. 1671-1684.e4
Open Access | Times Cited: 292

Showing 26-50 of 292 citing articles:

Targeting mTOR/YY1 signaling pathway by quercetin through CYP7A1-mediated cholesterol-to-bile acids conversion alleviated type 2 diabetes mellitus induced hepatic lipid accumulation
Tingting Yang, Yiying Wang, Xinyun Cao, et al.
Phytomedicine (2023) Vol. 113, pp. 154703-154703
Closed Access | Times Cited: 32
FXR agonists for MASH therapy: Lessons and perspectives from obeticholic acid
Kang Wang, Yuecan Zhang, Guangji Wang, et al.
Medicinal Research Reviews (2023) Vol. 44, Iss. 2, pp. 568-586
Closed Access | Times Cited: 28
Non-Alcoholic Fatty Liver Disease or Type 2 Diabetes Mellitus—The Chicken or the Egg Dilemma
Marcin Kosmalski, Agnieszka Śliwińska, Józef Drzewoski
Biomedicines (2023) Vol. 11, Iss. 4, pp. 1097-1097
Open Access | Times Cited: 26
Small Intestinal Bacterial Overgrowth and Non-Alcoholic Fatty Liver Disease: What Do We Know in 2023?
Anna Gudan, Katarzyna Kozłowska‐Petriczko, Ewa Wunsch, et al.
Nutrients (2023) Vol. 15, Iss. 6, pp. 1323-1323
Open Access | Times Cited: 25
The ameliorating effect of withaferin A on high-fat diet-induced non-alcoholic fatty liver disease by acting as an LXR/FXR dual receptor activator
Varsha D. Shiragannavar, Nirmala G. Sannappa Gowda, Lakshana D. Puttahanumantharayappa, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 24
Alteration of Gut Microbiota Composition in the Progression of Liver Damage in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
Alejandra Zazueta, Lucía Valenzuela-Pérez, Nicolás Ortiz‐López, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 8, pp. 4387-4387
Open Access | Times Cited: 13
Hepatic Zbtb18 (Zinc Finger and BTB Domain Containing 18) alleviates hepatic steatohepatitis via FXR (Farnesoid X Receptor)
Lei Zhang, Jiabing Chen, Xiaoying Yang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 11
A Current Understanding of FXR in NAFLD: The multifaceted regulatory role of FXR and novel lead discovery for drug development
Tang Yu-hong, Yujuan Fan, Yiming Wang, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 175, pp. 116658-116658
Open Access | Times Cited: 11
Diabetes as a risk factor for MASH progression
Sofiya Gancheva, Michael Roden, Laurent Castéra
Diabetes Research and Clinical Practice (2024) Vol. 217, pp. 111846-111846
Open Access | Times Cited: 11
Activation of Nrf2 and FXR via Natural Compounds in Liver Inflammatory Disease
Marta Belka, Aleksandra Gostyńska, Maciej Stawny, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 20, pp. 11213-11213
Open Access | Times Cited: 11
Dihydrotanshinone I Attenuates Diet‐Induced Nonalcoholic Fatty Liver Disease via Up‐Regulation of IRG1
Xiang Yang, Ge Kuang, Xia Gong, et al.
Phytotherapy Research (2025)
Closed Access | Times Cited: 1
Pathologic and therapeutic insights into cholestatic liver disease-associated depressive disorder
Xin Li, Hong Wang, Yufei Li, et al.
Acta Materia Medica (2025) Vol. 4, Iss. 2
Open Access | Times Cited: 1
The association between the dietary index for gut microbiota and non-alcoholic fatty liver disease and liver fibrosis: evidence from NHANES 2017–2020
Ce Zheng, Zeming Qi, Rui Chen, et al.
BMC Gastroenterology (2025) Vol. 25, Iss. 1
Open Access | Times Cited: 1
Updates on novel pharmacotherapeutics for the treatment of nonalcoholic steatohepatitis
Yong‐Yu Yang, Li Xie, Ning‐Ping Zhang, et al.
Acta Pharmacologica Sinica (2022) Vol. 43, Iss. 5, pp. 1180-1190
Open Access | Times Cited: 37
Penthorum chinense Pursh. extract attenuates non-alcholic fatty liver disease by regulating gut microbiota and bile acid metabolism in mice
Xiaoxi Li, Wenwen Zhao, Xiao Meng, et al.
Journal of Ethnopharmacology (2022) Vol. 294, pp. 115333-115333
Closed Access | Times Cited: 36
A new perspective on NAFLD: Focusing on the crosstalk between peroxisome proliferator-activated receptor alpha (PPARα) and farnesoid X receptor (FXR)
Shipeng Zhou, Huimin You, Shuting Qiu, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 154, pp. 113577-113577
Open Access | Times Cited: 36
When fat meets the gut—focus on intestinal lipid handling in metabolic health and disease
Magdalena Wit, Jonathan Trujillo Viera, Akim Strohmeyer, et al.
EMBO Molecular Medicine (2022) Vol. 14, Iss. 5
Open Access | Times Cited: 32
The contribution of the gut-liver axis to the immune signaling pathway of NAFLD
Jiayi Liu, Anding Wu, Jingjing Cai, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 29
Alterations in Circulating Bile Acids in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Systematic Review and Meta-Analysis
Jiaming Lai, Ling Luo, Ting Zhou, et al.
Biomolecules (2023) Vol. 13, Iss. 9, pp. 1356-1356
Open Access | Times Cited: 23
FXR and NASH: an avenue for tissue-specific regulation
Zakiyah Henry, Vik Meadows, Grace L. Guo
Hepatology Communications (2023) Vol. 7, Iss. 5
Open Access | Times Cited: 18
Recent advances towards mass spectrometry-based clinical lipidomics
Samira Salihović, Santosh Lamichane, Tuulia Hyötyläinen, et al.
Current Opinion in Chemical Biology (2023) Vol. 76, pp. 102370-102370
Open Access | Times Cited: 18
The role of bile acids in regulating glucose and lipid metabolism
Hengcai Yu, Ruifang Nie, Chengwu Shen
Endocrine Journal (2023) Vol. 70, Iss. 4, pp. 359-374
Open Access | Times Cited: 17
Modulation of the Microbiome–Fat–Liver Axis by Lactic Acid Bacteria: A Potential Alleviated Role in High-Fat-Diet-Induced Obese Mice
Benliang Wei, Zhen Peng, Muyan Xiao, et al.
Journal of Agricultural and Food Chemistry (2023) Vol. 71, Iss. 27, pp. 10361-10374
Closed Access | Times Cited: 17
Overview and prospect of NAFLD: Significant roles of nutrients and dietary patterns in its progression or prevention
Tianyu Mao, Yiwen Sun, Xinyi Xu, et al.
Hepatology Communications (2023) Vol. 7, Iss. 10
Open Access | Times Cited: 17
Bile Acid Diarrhea: From Molecular Mechanisms to Clinical Diagnosis and Treatment in the Era of Precision Medicine
Daiyu Yang, Chengzhen Lyu, Kun He, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 3, pp. 1544-1544
Open Access | Times Cited: 8

Scroll to top